|Articles|June 1, 2009

Pharmaceutical Executive

  • Pharmaceutical Executive-06-01-2009
  • Volume 0
  • Issue 0

Joe Mclane, Merck

I joined Merck in 1996 as a customer account representative, processing pharmaceutical and vaccine orders for our direct customers.

Joe McLane

Senior Manager, Global Marketing Communications, HPV Franchise, Merck

I joined Merck in 1996 as a customer account representative, processing pharmaceutical and vaccine orders for our direct customers. I wanted to have a career in pharma, and. more importantly, at Merck, because I wanted to be part of something bigger and make a difference. My major accomplishments so far include "Tell Someone," a disease campaign that educated women on the link between cervical cancer and human papillomavirus, and the launch of "One Less," our branded campaign that announced the availability of [HPV vaccine] Gardasil.

Social networks are the new frontier for pharma. Social networks, word-of-mouth initiatives, and other social media will help stimulate conversations. Consumers trust healthcare information they learn in social circles; we are now exploring how to work with these unique networks to further our messages.

In 10 years, I hope to be doing what I love to do with people who are as passionate as I am. I'm trying to convince myself that 40 is the new 30.

Articles in this issue

over 17 years ago

Hans Bishop, Bayer Healthcare

over 17 years ago

Jennifer Spear Smith, Wyeth

over 17 years ago

Stefan Platz, Roche

over 17 years ago

On the Right Pathways

over 17 years ago

Craig Dashefsky, Schering-Plough

over 17 years ago

Frank Karbe, Exelixis

over 17 years ago

Michelle Dipp, GlaxoSmithKline

Related to this article

EMA Steps Up Push for Greater Clinical Trial Transparency
European regulators are increasing pressure on clinical trial sponsors to report study results on time, rolling out new monitoring, reminders and guidance as patient advocates welcome the progress but question whether stronger oversight and enforcement will follow.